Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKCα inhibition
The new isothiocyanate 4-(methylthio)butylisothiocyanate selectively affects cell-cycle progression and apoptosis induction of human leukemia cells
Phase I trial of the polyamine analog N1,N14-diethylhomospermine (DEHSPM) in patients with advanced solid tumors
A phase I trial of daily oral 4′-N-benzoyl-staurosporine in combination with protracted continuous infusion 5-fluorouracil in patients with advanced solid malignancies*
Pharmacokinetic drug–drug interaction of the novel anticancer agent E7070 and acenocoumarol
Phase I and pharmacokinetic study of fostriecin given as an intravenous bolus daily for five consecutive days
Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma
Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors
Phase II study of CI-958 in patients with hormone refractory prostate carcinoma
A novel combination of cisplatin, irinotecan, and capecitabine in patients with advanced cancer
Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer